A Continuous, Fluorogenic Sirtuin 2 Deacylase Assay: Substrate Screening and Inhibitor Evaluation (vol 59, pg 1021, 2016)

被引：2
|
作者：
Galleano, Iacopo
Schiedel, Matthias
Jung, Manfred
Madsen, Andreas S.
Olsen, Christian A.
机构：
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2016年 / 59卷 / 06期
关键词：
D O I：
10.1021/acs.jmedchem.6b00239
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：2847 / 2847
页数：1
相关论文
共 5 条
  • [1] A Continuous, Fluorogenic Sirtuin 2 Deacylase Assay: Substrate Screening and Inhibitor Evaluation
    Galleano, Iacopo
    Schiedel, Matthias
    Jung, Manfred
    Madsen, Andreas S.
    Olsen, Christian A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (03) : 1021 - 1031
  • [2] Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate (vol 318, pg 862, 2004)
    Kuo, CJ
    Chi, YH
    Hsu, JTA
    Liang, PH
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (02) : 623 - 623
  • [3] Discovery of a Potent and Selective Coactivator Associated Arginine Methyltransferase 1 (CARM1) Inhibitor by Virtual Screening (vol 59, pg 6838, 2016)
    de Freitas, Renato Ferreira
    Eram, Mohammad S.
    Smil, David
    Szewczyk, Magdalena M.
    Kennedy, Steven
    Brown, Peter J.
    Santhakumar, Vijayaratnam
    Barsyte-Lovejoy, Dalia
    Arrowsmith, Cheryl H.
    Vedadi, Masoud
    Schapira, Matthieu
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (16) : 7698 - 7698
  • [4] Phase 2 multicentre trial investigating intermittent and continuous dosing schedules of the poly(ADP-ribose) polymerase inhibitor rucaparib in germline BRCA mutation carriers with advanced ovarian and breast cancer (vol 114, pg 723, 2016)
    Drew, Yvette
    Ledermann, Jonathan
    Hall, Geoff
    Rea, Daniel
    Glasspool, Ros
    Highley, Martin
    Jayson, Gordon
    Sludden, Julieann
    Murray, James
    Jamieson, David
    Halford, Sarah
    Acton, Gary
    Backholer, Zoe
    Mangano, Raffaella
    Boddy, Alan
    Curtin, Nicola
    Plummer, Ruth
    [J]. BRITISH JOURNAL OF CANCER, 2016, 114 (12) : E21 - E21
  • [5] Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (Groups 1, 2A and 2B). The summary report of the 6th collaborative study by CSGMT/JEMS center dot MMS (vol 389, pg 3, 1997)
    Morita, T
    Asano, N
    Awogi, T
    Sasaki, YF
    Sato, S
    Shimada, H
    Sutou, S
    Suzuki, T
    Wakata, A
    Sofuni, T
    Hayashi, M
    [J]. MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, 1997, 391 (03) : 259 - 267
1